A STAT News survey of nearly 1,000 NIH funded researchers, conducted in January and February 2026, reveals deepening disruptions across U.S. biomedical research. Over 28% of respondents have laid off lab personnel, more than 42% have canceled planned research projects, and 67% have advised students to pursue careers outside academia. Despite congressional intervention to block NIH budget cuts and court reversals of some grant terminations, only 35% of researchers with affected grants reported full funding restoration by the end of 2025. The damage is concentrated among early career scientists. According to the survey data, 81% of junior tenure track researchers said funding disruptions threaten their tenure prospects. UCLA's Center for Behavioral and Addiction Medicine shrank by 40% due to cuts, a diabetes prevention trial in Puerto Rico lost patients, and one researcher took a 95% pay cut to avoid laying off staff. Steve Shoptaw, who directs the UCLA center, described the situation: "This is like the Titanic hitting the iceberg. People are still eating at the table, music's still playing, and yet the ship is sinking." The same survey documents a parallel brain drain driven by immigration policy. A follow up analysis found that 14% of respondents had turned down international candidates due to visa and immigration changes, while 13% reported losing lab members to other countries. New requirements, including mandatory social media disclosure and extended processing delays, have disrupted academic timelines. The administration's expanded travel bans now affect applicants from nearly three dozen countries, up from seven in 2017. This year's Match Day produced the lowest five year rate of international medical graduates securing U.S. residencies. The Department of Homeland Security's new 100,000 dollar H 1B visa fee has raised particular concern; the Association of American Medical Colleges has urged DHS to exempt physicians and trainees who fill critical gaps in underserved areas, but attorneys say the criteria for "national interest" exemptions remain unclear. NIH has framed its policy adjustments as necessary to reduce redundancy and prioritize high impact research. Academic leaders counter that the changes create unpredictability that stifles long term discovery. The Association of American Universities has warned that abrupt funding shifts erode trust in federal research support, while the Federation of American Societies for Experimental Biology has called for multi year funding commitments to stabilize lab operations. Labs that have downsized face challenges rehiring personnel and restarting experiments, particularly when grant cycles span multiple fiscal years. For graduate students and postdoctoral researchers, the combined effects of funding instability and immigration barriers are accelerating career reevaluations at a time when NIH supports over 300,000 researchers across more than 2,500 institutions. A University of Alabama at Birmingham professor noted that top talent may increasingly favor institutions in Europe or Asia, where visa processes are more predictable and research funding is less volatile.